Voices
Davide Ciardiello: Results from the Randomized CAVE-2 GOIM Trial on Cetuximab Rechallenge in mCRC
Davide Ciardiello/LinkedIn

Davide Ciardiello: Results from the Randomized CAVE-2 GOIM Trial on Cetuximab Rechallenge in mCRC

Davide Ciardiello, Medical Oncologist at Division of Gastrointestinal and Neuroendocrine Tumors at European Institute of Oncology, shared a post on X:

“Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial – Annals of Oncology”

Title: Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial

Authors: D. Ciardiello, G. Martini, L. Boscolo Bielo, F. Pietrantonio, A. Raimondi, P. Manca, S. Pisconti, C. Nisi, G. Tortora, L. Salvatore, A. Sartore-Bianchi, S. Siena, L. Blasi, E. Ongaro, A. Zaniboni, C. Pinto, L. Antonuzzo, A. Avallone, N. Normanno, G. Santabarbara, M.G. Zampino, R. Berardi, A. Cogoni, C. Lotesoriere, T.P. Latiano, E. Maiello, N. Fazio, G. Curigliano, R. Bordonaro, T. Troiani, F. De Vita, E. Martinelli, F. Ciardiello, S. Napolitano

Read the Full Article on Annals of Oncology

Davide Ciardiello: Results from the Randomized CAVE-2 GOIM Trial on Cetuximab Rechallenge in mCRC

You can also read: CAVE-2 GOIM Trial Results: ctDNA-Guided Cetuximab Rechallenge in MSS RAS/BRAF Wild-Type Metastatic Colorectal Cancer

CAVE-2 GOIM trial results

A. Avallone A. Cogoni A. Raimondi A. Sartore-Bianchi A. Zaniboni C. Lotesoriere C. Nisi C. Pinto cancer CAVE-2 GOIM Trial colorectal cancer D. Ciardiello Davide Ciardiello E. Maiello E. Martinelli E. Ongaro F. Ciardiello F. De Vita F. Pietrantonio G Curigliano G. Martini G. Santabarbara G. Tortora L. Antonuzzo L. Blasi L. Boscolo Bielo L. Salvatore M.G. Zampino N. Fazio N. Normanno OncoDaily Oncology P. Manca R. Berardi R. Bordonaro S. Napolitano S. Pisconti S. Siena T. Troiani T.P. Latiano